Komori
Share Issuance and Disposal4572Carna Biosciences,Inc.Pharmaceuticals

Notice Regarding the Issuance of New Shares as Restricted Stock to Employees

The company resolved to issue 20,000 common shares to 1 employee, subject to transfer restrictions for the next 3 years. The employee will contribute a monetary claim of ¥6.2 million in kind and subscribe at ¥310 per share.

Worth reading
60In focus
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
20000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares as restricted stock to employees

Who receives how much20,000Shares

20,000 common shares (new shares)

1 company employee; 20,000 shares

The lower thin line represents the existing number of shares to which these shares will be added.

¥310 per share
Total issue value

¥6.2 million

Amount of funds to be raised
Total payment amount: ¥6.2 million; estimated net proceeds: Not disclosed
Total Stock-Based Compensation
Total monetary claim: ¥6.2 million
Conditions on transfer restrictions

Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.

Transfer restriction period
3 years from 15 December 2026 through 14 December 2029
Conditions for lifting transfer restrictions
The restrictions will be lifted on 15 December 2029, subject to the recipient having continuously held the position of director or employee of the company.
Reason for acquisition without consideration
All shares whose transfer restrictions have not been lifted when the restriction period expires will be acquired without consideration. If certain events occur, such as resignation or retirement for personal reasons, all or part of the shares will be acquired without consideration at that time.
Categories and Number of Persons Covered
1 company employee; 20,000 shares
Intended allottee's holding policy
Transfers, the creation of security interests and other dispositions will be prohibited from 15 December 2026 through 14 December 2029. The transfer restrictions will be lifted on 15 December 2029, subject to the employee having continuously held the position of director or employee of the company.
Payment date
15 December 2026
Basis for determining the amount to be paid
The closing price of the company's common shares on the Tokyo Stock Exchange on 18 November 2026 was ¥310. No discount or premium.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares as restricted stock to employees
Number of shares to be issued or disposed of20,000 common shares (new shares)
Issue price and disposal price¥310 per share
Total issue value¥6.2 million
Amount of funds to be raisedTotal payment amount: ¥6.2 million; estimated net proceeds: Not disclosed
Payment date15 December 2026
Intended allottee1 company employee; 20,000 shares
Intended allottee's holding policyTransfers, the creation of security interests and other dispositions will be prohibited from 15 December 2026 through 14 December 2029. The transfer restrictions will be lifted on 15 December 2029, subject to the employee having continuously held the position of director or employee of the company.
Basis for determining the amount to be paidThe closing price of the company's common shares on the Tokyo Stock Exchange on 18 November 2026 was ¥310. No discount or premium.
Transfer restriction period3 years from 15 December 2026 through 14 December 2029
Conditions for lifting transfer restrictionsThe restrictions will be lifted on 15 December 2029, subject to the recipient having continuously held the position of director or employee of the company.
Reason for acquisition without considerationAll shares whose transfer restrictions have not been lifted when the restriction period expires will be acquired without consideration. If certain events occur, such as resignation or retirement for personal reasons, all or part of the shares will be acquired without consideration at that time.
Categories and Number of Persons Covered1 company employee; 20,000 shares
Total Stock-Based CompensationTotal monetary claim: ¥6.2 million
Items this document does not state (14)
Estimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesExercise priceExercise periodNumber of Stock Acquisition RightsUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To provide employees with an incentive to achieve sustained growth in the Company’s corporate value.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Issuance of New Shares as Restricted Stock to Employees | Carna Biosciences,Inc. (4572) timely disclosure | Komori